Clinical Trials Logo

Sudden Cardiac Death clinical trials

View clinical trials related to Sudden Cardiac Death.

Filter by:

NCT ID: NCT00998218 Completed - Clinical trials for Sudden Cardiac Death

Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction

Start date: September 2009
Phase: Phase 3
Study type: Interventional

The purpose this investigation is to more thoroughly investigate the effects of ranolazine on arrhythmias and microvolt t-wave alternans in patients who have an automatic implantable cardioverter defibrillator (AICD) implanted either prophylactically to prevent sudden cardiac death, as well as in patients who may have had a clinically significant arrhythmic event prompting the insertion of the automatic implantable cardioverter defibrillator. It is anticipated this study will provide valuable new insight into the potential use of ranolazine to treat arrhythmias in higher risk patients.

NCT ID: NCT00944775 Completed - Clinical trials for Sudden Cardiac Death

Exercise and Cardiac Measures in Dialysis Patients

Start date: August 2007
Phase: N/A
Study type: Interventional

Background: The impact of the known non-invasive cardiac indices for identification of hemodialysis (HD) patients at high-risk for sudden cardiac death (SCD) has not been evaluated. Patients: Fifty-nine HD patients were randomized into 2 groups. Thirty of them (group A-aged 54.6±8.9 years) participated in a supervised training program with stationary bicycles during their HD sessions (3/weekly) for 10 months, while the rest (group B-aged 53.2±6.1 years) remained untrained and were used as controls. Study hypothesis: Exercise training will affect most of the non-invasive cardiac markers of SCD and the total score positively. Method: At entry, as well as at the end of the study all subjects underwent a cardiopulmonary exercise testing (estimation of aerobic capacity-VO2peak), an echocardiographic study (LV ejection fraction -LVEF evaluation), an ambulatory 24-hour Holter monitoring for cardiac autonomic nervous system activity evaluation by time- and frequency- domain heart rate variability (HRV) calculation (measurement of SDNN, mean RR and low to high frequency ratio-LF/HF), a signal-averaged ECG (late potentials-LP documentation) and a submaximal exercise test for microvolt-T-wave alternans (TWA) detection.

NCT ID: NCT00940888 Completed - Heart Failure Clinical Trials

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Start date: June 2009
Phase:
Study type: Observational

The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.

NCT ID: NCT00933218 Completed - Heart Failure Clinical Trials

Beer, Marathon, Genetics, Inflammation and the Cardiovascular System: Be-MaGIC-Trial

Be-MaGIC
Start date: June 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the myocardial function and vascular adaptation after strenuous exercise in association with consumption of polyphenols. The investigators aim to investigate the effects of extreme endurance exercise on the inflammatory system. Furthermore, the role of the cardiovascular response and adaptive mechanisms of the vasculature are examined. Subclinical injuries to the myocardium and vascular wall are being investigated.

NCT ID: NCT00916435 Completed - Clinical trials for Congestive Heart Failure

Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms

ICD-EGMs
Start date: March 2005
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: - to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and - to predict progression of heart failure in patients with ICD.

NCT ID: NCT00874445 Completed - Clinical trials for Sudden Cardiac Death

Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration

PROMISE
Start date: March 2009
Phase:
Study type: Observational

The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform in a single coil active can configuration.

NCT ID: NCT00848835 Completed - Clinical trials for Sudden Cardiac Death

Long Term Integrity Follow-up Evaluation

LEAD LIFE
Start date: March 2002
Phase: Phase 4
Study type: Observational

To document the performance of the Guidant ENDOTAK EZ and the RELIANCE defibrillation leads over 5 years.

NCT ID: NCT00845286 Completed - Heart Failure Clinical Trials

Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial

MAGIC
Start date: September 2008
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the myocardial function and vascular adaptation after strenuous exercise in association with genotype/polymorphisms. We aim to investigate the effects of extreme endurance exercise on the cardiovascular system. Furthermore, the role of the inflammatory response and adaptive mechanisms of the vasculature are examined. Subclinical injuries to the myocardium and vascular wall are being investigated.

NCT ID: NCT00780299 Completed - Cardiac Arrest Clinical Trials

Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability in Post-resuscitation Shock

Hyperdia
Start date: November 2, 2008
Phase: Phase 3
Study type: Interventional

Rationale: Despite spontaneous cardiac activity recovery, a shock occurs in more than half of patients after resuscitation for cardiac arrest. This acute circulatory insufficiency presents similar characteristics with septic shock and is responsible of most early deaths. Most frequently, usual treatments are unable to control this shock and to avoid the appearance of multiple organ failure. Aim of the study: In addition to conventional therapeutics, an early plasma epuration of inflammatory mediators (HDHP) could be able to improve hemodynamic parameters and to reduce the shock duration. This improvement could have an impact on multiple organ dysfunctions and also on early mortality.

NCT ID: NCT00748111 Completed - Clinical trials for Acute Myocardial Infarction

Thrombus and Inflammation Study in Sudden Cardiac DEath

TIDE
Start date: August 2008
Phase: N/A
Study type: Interventional

Sudden death is a natural death occurring within one hour after the onset of symptoms. It remains a major public health problem and accounts for 5 to 10 % of the annual total mortality ie about 300.000 in the United States. Despite community-based interventions, overall survival remains below 5%. Better understanding of the mechanisms causing sudden death could allow early identification of high risk subjects and implementation of specific prevention strategies. The cause of more than 90% of sudden deaths is cardiac with ventricular fibrillation or fast ventricular tachycardia complicating an underlying heart disease. Coronary heart disease and its consequences account for at least 80% of sudden cardiac deaths. Several risk factors associated with sudden death and not with myocardial infarction have been identified in population-based studies. However, the relationship between the occurrence of a coronary artery occlusion and the onset of arrhythmia is unclear. In particular, coronary artery occlusion can be rapidly followed by chest pain, which acts as a signal and allows identification of patients for emergency reperfusion. However, in some cases, the coronary artery occlusion is followed by a sudden onset of arrhythmia and sudden death. Recent data suggest that acute coronary occlusion is caused by plaque erosion or rupture and is followed by an intense local inflammation and rapid thrombus formation. Our hypothesis is that the speed of thrombus formation and coronary occlusion determines the clinical symptoms. Slow and progressive thrombus formation is likely to induce myocardial pre-conditioning thereby reducing the occurrence of ventricular arrhythmia. In contrast, rapid thrombus formation followed by acute coronary artery occlusion and ischemia is more likely to trigger fatal ventricular arrhythmia. During angioplasty procedures, coronary artery thrombus are aspirated, providing the opportunity for pathological studies. The aim of the TIDE study (Thrombus and Inflammation in Sudden Death) is therefore to compare the composition and age of thrombus collected at the site of coronary occlusion in patients with sudden death due to acute coronary artery occlusion and patients with an acute myocardial infarction without ventricular arrhythmia. The following hypothesis will be tested : fresh thrombus is more frequent in patients with sudden cardiac death versus patients with acute myocardial infarction without ventricular arrhythmia.